Cisapride-induced torsades de pointes

被引:55
作者
Vitola, J
Vukanovic, J
Roden, DM
机构
[1] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA
关键词
cisapride; potassium channels; torsades de pointes;
D O I
10.1111/j.1540-8167.1998.tb00888.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two cases of torsades de pointes associated with cisapride are presented, both in association with concomitant drug therapy that inhibits cisapride biotransformation, In one case, plasma cisapride was elevated days after the event, strongly supporting a role for accumulation of the drug in causing the arrhythmia, It is emphasized that these adverse drug reactions are not idiosyncratic, but rather are predictable based on an understanding of the underlying mechanisms.
引用
收藏
页码:1109 / 1113
页数:5
相关论文
共 38 条
[1]   Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus [J].
Annese, V ;
Lombardi, G ;
Frusciante, V ;
Germani, U ;
Andriulli, A ;
Bassotti, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (03) :599-603
[2]   Cisapride - Drug interactions of clinical significance [J].
Bedford, TA ;
Rowbotham, DJ .
DRUG SAFETY, 1996, 15 (03) :167-175
[3]   Grapefruit juice alters terfenadine pharmacokinetics resulting in prolongation of repolarization on the electrocardiogram [J].
Benton, RE ;
Honig, PK ;
Zamani, K ;
Cantilena, LR ;
Woosley, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (04) :383-388
[4]   LONG QT SYNDROME DURING HIGH-DOSE CISAPRIDE [J].
BRAN, S ;
MURRAY, WA ;
HIRSCH, IB ;
PALMER, JP .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (07) :765-768
[5]   Gastrointestinal problems in diabetes [J].
Camilleri, M .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (02) :361-&
[6]  
Carlsson L, 1997, J PHARMACOL EXP THER, V282, P220
[7]   THE EFFECT OF DIFFERENT DOSAGE SCHEDULES OF CISAPRIDE ON GASTRIC-EMPTYING IN IDIOPATHIC GASTROPARESIS [J].
CORINALDESI, R ;
STANGHELLINI, V ;
TOSETTI, C ;
REA, E ;
CORBELLI, C ;
MARENGO, M ;
MONETTI, N ;
BARBARA, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (05) :429-432
[8]  
CRUMB WJ, 1995, MOL PHARMACOL, V47, P181
[9]   PHARMACOGENETIC EXPLANATION FOR EXCESSIVE BETA-BLOCKADE FOLLOWING TIMOLOL EYE DROPS - POTENTIAL FOR ORAL-OPHTHALMIC DRUG-INTERACTION [J].
EDEKI, TI ;
HE, HB ;
WOOD, AJJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (20) :1611-1613
[10]   THE GENETIC-POLYMORPHISM OF DEBRISOQUINE SPARTEINE METABOLISM - CLINICAL ASPECTS [J].
EICHELBAUM, M ;
GROSS, AS .
PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) :377-394